Adipocytes-derived CXCL8 remodels the immune microenvironment of BC by suppressing the infiltration of CD4+/CD8+ T cells and upregulating CD274 (namely PD-L1) expression in TNBC (181). The gene discussed is CD8A; the disease is breast cancer.